Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06679803

Feasibility of a First-Line Physical Activity Intervention After Stroke

PA-ChatS: Feasibility of Delivering a First-Line Physical Activity Intervention After Stroke

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to explore a new intervention that supports physical activity within the first 6 weeks after stroke. All participants will complete assessments at weeks 0 and 7. During weeks 1 through 6, participants will use a Fitbit Inspire to track their step counts and meet with an occupational therapist one time per week. They will also complete weekly surveys. Physical activity levels will be measured using surveys and a wearable activPAL monitor 6 times during the study: Weeks 1, 3, 5, 7, 12, and 24.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPhysical Activity Chats after Stroke (PA-ChatS)PA-ChatS consists of (1) self-monitoring step count using a Fitbit Inspire, and (2) behavioral activation for stepping activity delivered via the telephone and guided by the PA-ChatS workbook. Participants will receive education regarding the physical activity after stroke, American Heart/Stroke Association guidelines for post-stroke physical activity levels, and an overview of the intervention activities. They will then use the Fitbit data to monitor average daily step counts, set a new step count goals (increasing by 5 to 10% of the daily average step count from the prior week), and create a specific plan for achieving the new step count goal. The interventionist will collaboratively problem solve with the participant to identify strategies to overcome barriers to stepping activity and maintain safety.

Timeline

Start date
2025-02-05
Primary completion
2026-08-30
Completion
2026-12-30
First posted
2024-11-08
Last updated
2026-02-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06679803. Inclusion in this directory is not an endorsement.